Clinical Trial

Neurocognitive Assessment CNSL and LGG

Name: Neurocognitive Assessment CNSL and LGG — clinical trial record (NCT07710131)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study is to determine whether self-administered digital cognitive tests can serve as accurate and reliable alternatives to established neuropsychological tests for evaluating cognitive functioning in participants with primary central nervous system lymphoma and low-grade gliomas.

Trial Details

NCT Number	NCT07710131
Lead Sponsor	Dana-Farber Cancer Institute
Conditions	PCNSL, Brain Tumor, Cognitive Dysfunction, IDH Mutation, Low-grade Glioma
Enrollment	36 participants
Start Date	2026-09-01
Primary Completion	2028-01-01 (estimated)
Study Completion	2029-01-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-17